NDATOPICALGEL
Approved
Jul 2015
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
5/8 — Partial
EPIDUO FORTE (adapalene and benzoyl peroxide) by Galderma is protein. Approved for acne vulgaris. First approved in 2015.
Drug data last refreshed Yesterday · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
EPIDUO FORTE is a fixed-dose topical gel combining adapalene (a retinoid modulator) and benzoyl peroxide (an oxidizing bactericidal agent) for treating acne vulgaris. Adapalene modulates cellular differentiation and keratinization while benzoyl peroxide provides antimicrobial and keratolytic effects. The combination addresses multiple pathogenic pathways of acne in a single formulation.
$0.077BPart D
PeakStable
Product is at peak commercial maturity with moderate Part D utilization; brand teams focus on market maintenance and defensive positioning against generic/OTC competition.
Mechanism of Action
protein. Biochemical and pharmacological profile studies have demonstrated that adapalene is a modulator of cellular differentiation, keratinization and inflammatory processes. However, the significance of these findings with regard to the mechanism of action of adapalene for the treatment of acne…
Pharmacologic Class:
Retinoid
Indications (1)
Career Relevance
Working on EPIDUO FORTE offers exposure to dermatology market dynamics, competitive positioning, and brand defense strategies in a mature topical category. The product is sponsored by Galderma, a specialized dermatology company, providing focused career development in a therapeutic-specific organization.
Worked on EPIDUO FORTE at Galderma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.